Key drivers of investment initiatives in Uganda's pharmaceutical industry
Related Experiment Video
Updated: Jul 4, 2025

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
Bernard Onyinyi1, Nashira Asiimwe2
1Makerere University Business School, Economics Department, Kampala, Uganda.
Abstract:
This study examines the key drivers of investment initiatives in Uganda's pharmaceutical industry. We adopted a qualitative research design using an in-depth interview guide to collect data from 12 board chairpersons/assistants at the selected manufacturing, marketing and sales pharmaceutical firms. The theory of Investment Behavior (Jorgenson, 1967) was used to underpin the actors' investment objectives beyond profit maximization locus subject to utility maximization. The results indicate two complementary investment drivers in pharmaceuticals: an investment gap and government policy initiatives. We recommend that the government should formulate an integrated human resource planning policy and further establish a one-in-all-stop hub to support pharmaceutical investments in the country. Besides, the hub should take charge of the operationalization of government policy initiatives intended to close the investment gap in the pharmaceutical industry.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Clinical Trials: Overview
Drug Discovery: Overview
Biopharmaceutics and Pharmacokinetics: Overview

